Foresite Capital Management Iv, Llc - Net Worth and Insider Trading

Foresite Capital Management Iv, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Foresite Capital Management Iv, Llc owns 4 companies in total, including Aerie Pharmaceuticals Inc (AERI) , 10x Genomics Inc (TXG) , and Aclaris Therapeutics Inc (ACRS) among others .

Click here to see the complete history of Foresite Capital Management Iv, Llc’s form 4 insider trades.

Insider Ownership Summary of Foresite Capital Management Iv, Llc

Ticker	Comapny	Transaction Date	Type of Owner
AERI	Aerie Pharmaceuticals Inc	2019-08-12	10 percent owner
TXG	10x Genomics Inc	2019-09-11	10 percent owner
ACRS	Aclaris Therapeutics Inc	2021-02-05	10 percent owner
		2020-12-02	10 percent owner

Foresite Capital Management Iv, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Foresite Capital Management Iv, Llc Ownership Network

Ownership Network List of Foresite Capital Management Iv, Llc

No Data

Ownership Network Relation of Foresite Capital Management Iv, Llc

Foresite Capital Management Iv, Llc Owned Company Details

What does Aerie Pharmaceuticals Inc do?

Who are the key executives at Aerie Pharmaceuticals Inc?

Foresite Capital Management Iv, Llc is the 10 percent owner of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .

Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerie Pharmaceuticals Inc Insider Transactions

No Available Data

What does 10x Genomics Inc do?

Who are the key executives at 10x Genomics Inc?

Foresite Capital Management Iv, Llc is the 10 percent owner of 10x Genomics Inc. Other key executives at 10x Genomics Inc include director & 10 percent owner & Chief Executive Officer Serge Saxonov , director & See Remarks Benjamin J. Hindson , and Chief Financial Officer Justin J. Mcanear .

10x Genomics Inc (TXG) Insider Trades Summary

Over the past 18 months, Foresite Capital Management Iv, Llc made no insider transaction in 10x Genomics Inc (TXG). Other recent insider transactions involving 10x Genomics Inc (TXG) include a net sale of 93,946 shares made by Serge Saxonov , a net sale of 41,247 shares made by Benjamin J. Hindson , and a net sale of 12,784 shares made by Justin J. Mcanear .

In summary, during the past 3 months, insiders sold 14,061 shares of 10x Genomics Inc (TXG) in total and bought 0 shares, with a net sale of 14,061 shares. During the past 18 months, 186,174 shares of 10x Genomics Inc (TXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 186,174 shares.

10x Genomics Inc (TXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

10x Genomics Inc Insider Transactions

No Available Data

What does Aclaris Therapeutics Inc do?

Who are the key executives at Aclaris Therapeutics Inc?

Foresite Capital Management Iv, Llc is the 10 percent owner of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .

Aclaris Therapeutics Inc (ACRS) Insider Trades Summary

Over the past 18 months, Foresite Capital Management Iv, Llc made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 18,000 shares made by Joseph Monahan , and a net purchase of 14,705 shares made by James Loerop .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 4,878,247 shares were bought by its insiders, resulting in a net purchase of 4,860,247 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aclaris Therapeutics Inc Insider Transactions

No Available Data

What does Kinnate Biopharma Inc do?

Who are the key executives at Kinnate Biopharma Inc?

Foresite Capital Management Iv, Llc is the 10 percent owner of Kinnate Biopharma Inc. Other key executives at Kinnate Biopharma Inc include director & 10 percent owner James B. Tananbaum , 10 percent owner Foresite Capital Fund Iv, L.p. , and director & 10 percent owner Orbimed Capital Gp Viii Llc .

Kinnate Biopharma Inc (KNTE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kinnate Biopharma Inc (KNTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kinnate Biopharma Inc (KNTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kinnate Biopharma Inc (KNTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kinnate Biopharma Inc Insider Transactions

No Available Data

Foresite Capital Management Iv, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Foresite Capital Management Iv, Llc. You might contact Foresite Capital Management Iv, Llc via mailing address: 900 Larkspur Landing Circle, Suite 150, Larkspur Ca 94939.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.